Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
202.13B
Market cap202.13B
Price-Earnings ratio
31.27
Price-Earnings ratio31.27
Dividend yield
2.06%
Dividend yield2.06%
Average volume
8.03M
Average volume8.03M
High today
$116.82
High today$116.82
Low today
$115.58
Low today$115.58
Open price
$115.71
Open price$115.71
Volume
7.91M
Volume7.91M
52 Week high
$141.23
52 Week high$141.23
52 Week low
$105.27
52 Week low$105.27

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $116.32. The company's market cap stands at 202.13B, with a P/E ratio of 31.27 and a dividend yield of 2.1%.

During the trading session on 2026-02-27, Abbott(ABT) shares reached a daily high of $116.82 and a low of $115.58. At a current price of $116.32, the stock is +0.6% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 7.91M, compared to an average daily volume of 8.03M.

The stock's 52-week range extends from a low of $105.27 to a high of $141.23.

The stock's 52-week range extends from a low of $105.27 to a high of $141.23.

ABT News

TipRanks 41m
FDA approves Abbott CardioMEMS Hero device for people living with heart failure

Abbott (ABT) announced the FDA has approved the company’s CardioMEMS Hero device – a pulmonary artery pressure reader – to support the care of people living wit...

TipRanks 22h
Abbott Laboratories Prices $20 Billion Senior Notes Offering

Abbott Laboratories ( (ABT) ) has provided an update. On February 23, 2026, Abbott Laboratories entered into a pricing agreement with a syndicate of major inve...

Simply Wall St 1d
Abbott’s US$20b Bond Bet Recasts Growth Story In Oncology Diagnostics

Abbott Laboratories (NYSE:ABT) is acquiring cancer diagnostics company Exact Sciences in a deal financed by a US$20b bond sale. The transaction marks Abbott's...

Abbott’s US$20b Bond Bet Recasts Growth Story In Oncology Diagnostics

Analyst ratings

71%

of 31 ratings
Buy
71%
Hold
29%
Sell
0%

More ABT News

The Motley Fool 2d
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time

Abbott Laboratories is delivering double-digit percentage earnings growth along with a dependable dividend. Tilray Brands (TLRY +0.00%), like many other cannab...

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
Simply Wall St 3d
Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight

A wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' FreeStyle Libre 3 and Libre 3 Plus glucose monitors. The complaint links the d...

Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight
The Motley Fool 4d
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich

"Boring" may be just what the doctor ordered in this volatile market. Over the past few years, the exciting field of artificial intelligence (AI) has captured...

Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich
Simply Wall St 4d
A Look At Abbott Laboratories Valuation After Recent Share Price Moves

Advertisement Why Abbott Laboratories (ABT) is Back on Investors’ Radar Abbott Laboratories (ABT) is drawing fresh attention after recent share price moves, w...

A Look At Abbott Laboratories Valuation After Recent Share Price Moves
TipRanks 7d
Exact Sciences shareholders approve acquisition by Abbott

Exact Sciences (EXAS) announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (ABT) at the special meeting of stoc...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.